The Role of Fructose as a Cardiovascular Risk Factor: An Update
Abstract
:1. Introduction: The Global Problem of CVD and the Nutrition Role of Sugars and Fructose
2. Fructose and Nutrition: Sources of Fructose and Its Mechanism of Action
3. Fructose and Cardiovascular Risk
Study | Year | Primary Endpoint | Main Findings |
---|---|---|---|
Teff KL et al. [8] Dietary fructose decreases the circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women | 2004 | Testing whether meals high in fructose (HFr) would result in lower leptin concentrations than meals containing the same amount of glucose (HGl) | Consuming HFr beverages with meals results in lower circulating insulin and leptin concentrations and higher ghrelin and triglyceride levels compared with consumption of HGl beverages |
Aeberli I et al. [29] Fructose intake is a predictor of LDL particle size in overweight schoolchildren | 2007 | To determine whether LDL particle size is associated with fructose intake in normal-weight and overweight children | Greater total and central adiposity are associated with smaller LDL size and lower HDL cholesterol. Additionally, higher fructose intake predicts smaller LDL particle size |
Stanhope KL et al. [25] Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | 2009 | To assess the relative effects of fructose-sweetened and glucose-sweetened beverages on lipid and glucose metabolism in humans, overweight, and obese subjects | Dietary fructose increases hepatic de novo lipogenesis, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults |
Cox CL et al. [26] Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol-binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans | 2012 | Investigating the relative effects of 10 weeks of fructose or glucose consumption on plasma uric acid, retinol binding protein-4, and liver enzyme activities in men and women | Consumption of fructose, but not glucose, led to significant increases in 24-h uric acid profiles and retinol binding protein-4 concentrations, as well as plasma gamma-glutamyl transferase activity |
de Castro UG et al. [11] Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats | 2013 | Evaluating biochemical, physiological, histological, and biometric parameters in rats with a high-fat or high-fructose diet | High-fructose diet caused the most significant change in the metabolism of serum lipids and lipid accumulation in the liver and kidney, while a high-fat diet induced elevation of arterial pressure and heart rate and increased visceral lipid stores |
Morenga LA et al. [24] Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids | 2014 | Systematic review and meta-analysis of randomized controlled trials that examined effects of the modification of dietary free sugars (mostly fructose) on blood pressure and lipids | Higher intake of sugars is associated with increased concentrations of triglycerides, total and LDL cholesterol, and blood pressure (this last effect was significant in studies of a longer duration only) |
Yoo S et al. [21] High dietary fructose intake on cardiovascular disease-related parameters in growing rats | 2016 | Determining the effects of a high-fructose diet on cardiovascular disease-related parameters in growing rats | High-fructose diet increased total-fat weight and serum triglyceride levels. Negative effects were found in abdominal aortic thickness, as well as endothelial nitric oxide synthase and endothelin-1 mRNA expression |
Gungor A et al. [31] The relationship between daily fructose consumption and oxidized low-density lipoprotein and low-density lipoprotein particle size in children with obesity | 2021 | To investigate the relationship between fructose consumption and obesity and the role of fructose consumption in development of atherosclerosis in obese and healthy children | The overconsumption of fructose in children triggers atherogenic diseases by increasing the levels of small, dense LDL |
4. Conclusions
Funding
Conflicts of Interest
References
- Amini, M.; Zayeri, F.; Salehi, M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health 2021, 21, 401. [Google Scholar] [CrossRef]
- Brandhorst, S.; Longo, V.D. Dietary Restrictions and Nutrition in the Prevention and Treatment of Cardiovascular Disease. Circ. Res. 2019, 124, 952–965. [Google Scholar] [CrossRef]
- Davis, P.H.; Dawson, J.D.; Riley, W.A.; Lauer, R.M. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation 2001, 104, 2815–2819. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Marhuenda, J.; Villaño, D.; Cerdá, B.; Zafrilla, M.P. Cardiovascular disease and nutrition. In Nutrition in Health and Disease-Our Challenges Now and Forthcoming Time; IntechOpen: London, UK, 2019. [Google Scholar]
- Rippe, J.M.; Angelopoulos, T.J. The Role of Nutrition and Lifestyle in the Prevention and Treatment of Cardiovascular Disease. In Nutrition in Lifestyle Medicine; Humana Press: Cham, Switzerland, 2017; pp. 137–150. [Google Scholar]
- Dandona, P.; Aljada, A.; Bandyopadhyay, A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25, 4–7. [Google Scholar] [CrossRef]
- Laughlin, M.R. Normal roles for dietary fructose in carbohydrate metabolism. Nutrients 2014, 6, 3117–3129. [Google Scholar] [CrossRef] [Green Version]
- Teff, K.L.; Elliott, S.S.; Tschöp, M.; Kieffer, T.J.; Rader, D.; Heiman, M.; Townsend, R.R.; Keim, N.L.; D’Alessio, D.; Havel, P.J. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J. Clin. Endocrinol. Metab. 2004, 89, 2963–2972. [Google Scholar] [CrossRef] [PubMed]
- Structural Formula of Fructose. Available online: https://www.chem.purdue.edu/jmol/molecules/fruc.html (accessed on 14 December 2021).
- White, J.S. Challenging the fructose hypothesis: New perspectives on fructose consumption and metabolism. Adv. Nutr. 2013, 4, 246–256. [Google Scholar] [CrossRef] [Green Version]
- De Castro, U.G.; dos Santos, R.A.; Silva, M.E.; de Lima, W.G.; Campagnole-Santos, M.J.; Alzamora, A.C. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids Health Dis. 2013, 12, 136. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lakhan, S.E.; Kirchgessner, A. The emerging role of dietary fructose in obesity and cognitive decline. Nutr. J. 2013, 12, 114. [Google Scholar] [CrossRef] [Green Version]
- Pereira, R.M.; Botezelli, J.D.; da Cruz Rodrigues, K.C.; Mekary, R.A.; Cintra, D.E.; Pauli, J.R.; da Silva, A.S.R.; Ropelle, E.R.; de Moura, L.P. Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism. Nutrients 2017, 9, 405. [Google Scholar] [CrossRef] [Green Version]
- Bandini, L.G.; Vu, D.; Must, A.; Cyr, H.; Goldberg, A.; Dietz, W.H. Comparison of high-calorie, low-nutrient-dense food consumption among obese and non-obese adolescents. Obes. Res. 1999, 7, 438–443. [Google Scholar] [CrossRef]
- Bray, G.A. Fructose and risk of cardiometabolic disease. Curr. Atheroscler. Rep. 2012, 14, 570–578. [Google Scholar] [CrossRef] [PubMed]
- Visseren, F.L.; Mach, F.; Smulders, Y.M.; Carballo, D.; Koskinas, K.C.; Bäck, M.; Benetos, A.; Biffi, A.; Boavida, J.M.; Capodanno, D. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Eur. Heart J. 2021, 42, 3227–3337. [Google Scholar] [CrossRef] [PubMed]
- Johnson, R.K.; Appel, L.J.; Brands, M.; Howard, B.V.; Lefevre, M.; Lustig, R.H.; Sacks, F.; Steffen, L.M.; Wylie-Rosett, J. Dietary sugars intake and cardiovascular health: A scientific statement from the American Heart Association. Circulation 2009, 120, 1011–1020. [Google Scholar] [CrossRef] [PubMed]
- Yang, Q.; Zhang, Z.; Gregg, E.W.; Flanders, W.D.; Merritt, R.; Hu, F.B. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern. Med. 2014, 174, 516–524. [Google Scholar] [CrossRef] [Green Version]
- Miller, A.; Adeli, K. Dietary fructose and the metabolic syndrome. Curr. Opin. Gastroenterol. 2008, 24, 204–209. [Google Scholar] [CrossRef] [Green Version]
- The Korea National Health and Nutrition Examination Survey (KNHNES). Dietary Intake Survey of Infant, Children and Adolescents; The Korea National Health and Nutrition Examination Survey: Cheongju, Korea, 2011. [Google Scholar]
- Yoo, S.; Ahn, H.; Park, Y.K. High Dietary Fructose Intake on Cardiovascular Disease-Related Parameters in Growing Rats. Nutrients 2016, 9, 11. [Google Scholar] [CrossRef] [Green Version]
- Tobey, T.A.; Mondon, C.E.; Zavaroni, I.; Reaven, G.M. Mechanism of insulin resistance in fructose-fed rats. Metabolism 1982, 31, 608–612. [Google Scholar] [CrossRef]
- Tran, L.T.; Yuen, V.G.; McNeill, J.H. The fructose-fed rat: A review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol. Cell. Biochem. 2009, 332, 145–159. [Google Scholar] [CrossRef]
- Morenga, L.A.; Te Howatson, A.J.; Jones, R.M.; Mann, J. Dietary sugars and cardiometabolic risk: Systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am. J. Clin. Nutr. 2014, 100, 65–79. [Google Scholar] [CrossRef] [Green Version]
- Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.; Dyachenko, A.; Zhang, W.; et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119, 1322–1334. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cox, C.L.; Stanhope, K.L.; Schwarz, J.M.; Graham, J.L.; Hatcher, B.; Griffen, S.C.; Bremer, A.A.; Berglund, L.; McGahan, J.P.; Keim, N.L.; et al. Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol-binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr. Metab. 2012, 9, 68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lanaspa, M.A.; Cicerchi, C.; Garcia, G.; Li, N.; Roncal-Jimenez, C.A.; Rivard, C.J.; Hunter, B.; Andrés-Hernando, A.; Ishimoto, T.; Sánchez-Lozada, L.G.; et al. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS ONE 2012, 7, e48801. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Russo, E.; Leoncini, G.; Esposito, P.; Garibotto, G.; Pontremoli, R.; Viazzi, F. Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. Int. J. Mol. Sci. 2020, 21, 4479. [Google Scholar] [CrossRef]
- Aeberli, I.; Zimmermann, M.B.; Molinari, L.; Lehmann, R.; l’Allemand, D.; Spinas, G.A.; Berneis, K. Fructose intake is a predictor of LDL particle size in overweight schoolchildren. Am. J. Clin. Nutr. 2007, 86, 1174–1178. [Google Scholar] [CrossRef] [Green Version]
- Gerber, P.A.; Berneis, K. Regulation of low-density lipoprotein subfractions by carbohydrates. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 381–385. [Google Scholar] [CrossRef] [Green Version]
- Gungor, A.; Balamtekin, N.; Ozkececi, C.F.; Aydin, H.İ. The Relationship between Daily Fructose Consumption and Oxidized Low-Density Lipoprotein and Low-Density Lipoprotein Particle Size in Children with Obesity. Pediatr. Gastroenterol. Hepatol. Nutr. 2021, 24, 483–491. [Google Scholar] [CrossRef]
- Rizzo, M.; Berneis, K. Who needs to care about small, dense low-density lipoproteins? Int. J. Clin. Pract. 2007, 61, 1949–1956. [Google Scholar] [CrossRef]
- Berneis, K.; Rizzo, M.; Stettler, C.; Chappuis, B.; Braun, M.; Diem, P.; Christ, E.R. Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes. Expert Opin. Pharmacother. 2008, 9, 343–349. [Google Scholar] [CrossRef]
- Rizzo, M.; Nikolic, D.; Patti, A.M.; Mannina, C.; Montalto, G.; McAdams, B.S.; Rizvi, A.A.; Cosentino, F. GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms. Biochim. Biophys. Acta Mol. Basis Dis. 2018, 1864, 2814–2821. [Google Scholar] [CrossRef]
- DiStefano, J.K. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. Cell. Mol. Life Sci. 2020, 77, 2079–2090. [Google Scholar] [CrossRef] [PubMed]
- Stoian, A.P.; Banerjee, Y.; Rizvi, A.A.; Rizzo, M. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab. Syndr. Relat. Disord. 2020, 18, 173–175. [Google Scholar] [CrossRef] [PubMed]
- Al Mahmeed, W.; Al-Rasadi, K.; Banerjee, Y.; Ceriello, A.; Cosentino, F.; Galia, M.; Goh, S.Y.; Kempler, P.; Lessan, N.; Papanas, N.; et al. Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel. Front. Cardiovasc. Med. 2021, 8, 787761. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Busnatu, S.-S.; Salmen, T.; Pana, M.-A.; Rizzo, M.; Stallone, T.; Papanas, N.; Popovic, D.; Tanasescu, D.; Serban, D.; Stoian, A.P. The Role of Fructose as a Cardiovascular Risk Factor: An Update. Metabolites 2022, 12, 67. https://doi.org/10.3390/metabo12010067
Busnatu S-S, Salmen T, Pana M-A, Rizzo M, Stallone T, Papanas N, Popovic D, Tanasescu D, Serban D, Stoian AP. The Role of Fructose as a Cardiovascular Risk Factor: An Update. Metabolites. 2022; 12(1):67. https://doi.org/10.3390/metabo12010067
Chicago/Turabian StyleBusnatu, Stefan-Sebastian, Teodor Salmen, Maria-Alexandra Pana, Manfredi Rizzo, Tiziana Stallone, Nikolaos Papanas, Djordje Popovic, Denisa Tanasescu, Dragos Serban, and Anca Pantea Stoian. 2022. "The Role of Fructose as a Cardiovascular Risk Factor: An Update" Metabolites 12, no. 1: 67. https://doi.org/10.3390/metabo12010067